2022 December ACSoMP recommendations

Overview

Following the WHO transformation in 2020, in which the work related to the safety of medicines and vaccines were combined within the Regulation and Safety Unit (REG), joint meetings of the Advisory Committee on Safety of Medicinal Products (ACSoMP) and the Global Advisory Committee on Vaccine Safety (GACVS) were established. A summary of the presentations and recommendations from the medicines-specific sessions and from sessions of common interest for the pharmacovigilance of both medicines and vaccines is provided below. The medicines-specific sessions were co-chaired by Dr June Raine from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) and Dr Gerald Dal Pan from the United States Food and Drug Administration (USFDA) and sessions common to both vaccines and medicines were co-chaired by Dr Dure Samin Akram from the Health, Education and Literacy Program in Pakistan and Dr Gerald Dal Pan.